| # | Drug | Count |
|---|---|---|
| 0 | NIVOLUMAB | 5 |
| 1 | IPILIMUMAB | 3 |
| 2 | OCTREOTIDE ACETATE | 2 |
| 3 | PEGVISOMANT | 2 |
| 4 | SOMATROPIN | 2 |
| 5 | ANTI ITCH | 1 |
| 6 | ANTI-ITCH | 1 |
| 7 | ANTI-ITCH CREAM | 1 |
| 8 | ANTI-PRURITIC | 1 |
| 9 | ANTIPRURITIC (ANTI-ITCH) | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PEGVISOMANT | 2 | 0.0005 |
| 1 | ESLICARBAZEPINE ACETATE | 1 | 0.0003 |
| 2 | LECANEMAB | 1 | 0.0003 |
| 3 | LANREOTIDE ACETATE | 1 | 0.0001 |
| 4 | VEMURAFENIB | 1 | 0.0001 |
| 5 | IPILIMUMAB | 3 | 0.0001 |
| 6 | OCTREOTIDE ACETATE | 2 | 0.0001 |
| 7 | EXTENDED PHENYTOIN SODIUM | 1 | 0.0001 |
| 8 | NIVOLUMAB | 5 | 0.0001 |
| 9 | ARMODAFINIL | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Amyloid Beta-directed Antibody [EPC] | 1 | 0.0003 |
| 1 | CTLA-4-directed Blocking Antibody [EPC] | 3 | 0.0001 |
| 2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 5 | 0.0001 |
| 3 | Programmed Death Ligand-1 Blocker [EPC] | 1 | 0.0000 |
| 4 | Recombinant Human Growth Hormone [EPC] | 1 | 0.0000 |
| 5 | Sympathomimetic-like Agent [EPC] | 1 | 0.0000 |
| 6 | 5-alpha Reductase Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Parathyroid Hormone Analog [EPC] | 1 | 0.0000 |
| 8 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Estrogen [EPC] | 1 | 0.0000 |